US Broker Ratings

TruBridge, Inc. (TBRG) Investor Outlook: A Glimpse Into a Potential 21.60% Upside

TruBridge, Inc. (NASDAQ: TBRG), a prominent player in the healthcare sector, operates within the health information services industry, providing critical solutions to enhance financial health and patient care for healthcare..

ClearPoint Neuro Inc. (CLPT): Investor Outlook Reveals 116.90% Potential Upside in Medical Devices Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT), a pioneering player in the healthcare sector’s medical devices industry, is capturing investor attention with its impressive potential upside of 116.90%. Specializing in minimally invasive..

Wave Life Sciences Ltd. (WVE) Stock Analysis: A Biotech with 145% Upside Potential

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company based in Singapore, is capturing the attention of investors with its innovative approach to RNA medicine. With a market capitalization..

The Pennant Group, Inc. (PNTG) Stock Report: A Promising 21.75% Upside for Healthcare Investors

The Pennant Group, Inc. (NASDAQ: PNTG) is emerging as a compelling opportunity for investors within the healthcare sector. With a robust market capitalization of $1.07 billion, this Idaho-based company operates..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a 41.94% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX) is garnering attention in the healthcare sector, particularly among investors eyeing its promising potential upside. With a market capitalization of $1.82 billion, this biopharmaceutical company..

Harrow, Inc. (HROW) Stock Analysis: A 48% Upside in the Promising Ophthalmic Pharmaceuticals Sector

Harrow, Inc. (NASDAQ: HROW), a noteworthy entity in the healthcare sector, is capturing investor attention with a formidable 48.81% potential upside. Specializing in the development and commercialization of ophthalmic pharmaceutical..

Vera Therapeutics, Inc. (VERA) Stock Analysis: A 71% Upside Potential in the Biotech Arena

In the dynamic world of biotechnology, Vera Therapeutics, Inc. (NASDAQ: VERA) emerges as a compelling player with significant upside potential. With a market capitalization of $3.11 billion, the California-based company..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 10.35% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the healthcare sector, has attracted attention for its promising potential upside of 10.35%. Specializing in both generic and proprietary injectable, inhalation,..

Guardian Pharmacy Services, Inc (GRDN): Stock Analysis Reveals 2.67% Potential Upside Amid Robust Revenue Growth

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) has garnered significant attention from investors, positioning itself as a noteworthy player in the healthcare sector, specifically within medical care facilities. With a market..

Liquidia Corporation (LQDA) Stock Analysis: Exploring a 1,121% Revenue Surge in Biotech

Liquidia Corporation (NASDAQ: LQDA), a pioneering entity in the biotechnology sector, has recently captured the attention of investors with its remarkable revenue growth, reaching an astonishing 1,121.70%. This surge highlights..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 24.77% Upside Potential in the Medical Devices Sector

For investors seeking opportunities in the healthcare sector, AdaptHealth Corp. (NASDAQ: AHCO) presents a compelling case. As a prominent player in the medical devices industry, AdaptHealth specializes in the distribution..

Omnicell, Inc. (OMCL) Stock Analysis: Unpacking a Potential 57% Upside in Healthcare Automation

Omnicell, Inc. (NASDAQ: OMCL) is an intriguing player in the healthcare sector, particularly within the health information services industry. Known for providing medication management solutions and adherence tools, Omnicell’s innovative..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating Market Challenges with Cutting-Edge Genomics Technology

10x Genomics, Inc. (NASDAQ: TXG), a prominent player in the healthcare sector, particularly in health information services, offers investors a fascinating case study in the intersection of cutting-edge technology and..

NeoGenomics, Inc. (NEO) Stock Analysis: Healthcare Diagnostics Firm with 27% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With its headquarters in Fort Myers, Florida, NeoGenomics has carved out..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Potential Upside Amidst Steady Healthcare Demand

Pediatrix Medical Group, Inc. (NYSE: MD) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.82 billion, the company..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: High Growth and 82% Potential Upside for Savvy Investors

Alphatec Holdings, Inc. (NASDAQ: ATEC) is carving a notable path in the healthcare sector, specifically within the medical devices industry. With a current market capitalization of $2.01 billion, this Carlsbad,..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: 42% Potential Upside Amidst Breakthrough Biotechnology Advances

Investors with a keen interest in the biotechnology sector should keep an eye on Viridian Therapeutics, Inc. (NASDAQ: VRDN), a dynamic player in the healthcare industry. With a market capitalization..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Potential 19.79% Upside and Robust Growth in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a key player in the medical instruments and supplies industry, is capturing investor attention with its promising potential upside of 19.79% and a strong foothold..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: A Promising 13.4% Upside Potential

Healthcare Services Group, Inc. (NASDAQ: HCSG), a key player in the healthcare sector, operates within the medical care facilities industry. Based in Bensalem, Pennsylvania, HCSG provides essential management and operational..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Unveiling a 130% Potential Upside

Dyne Therapeutics, Inc. (NASDAQ: DYN) has emerged as a captivating player in the biotechnology sector, particularly for investors eyeing the healthcare domain. Specializing in neuromuscular disease therapeutics, Dyne is focused..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds